Shares of Bristol Myers Squibb Co. rallied 3.59% to $54.29 Monday, on what proved to be an all-around grim trading session ...

Bank of America upgrades Bristol Myers to Buy, lifting its price target to $61 on pipeline catalysts, valuation support, and ...

Bristol Myers Squibb, one of the world’s largest biopharmaceutical companies, and Accenture, a global professional services ...

What Happened? Shares of biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) jumped 3.7% in the afternoon session after ...

Over 500 industry leaders gathered at the Dublin Royal Convention Centre to celebrate excellence in Ireland’s pharma sector ...

If you are wondering whether Bristol-Myers Squibb is quietly becoming a value opportunity or just a classic value trap, you ...

Futures are trading higher on Monday as we head into the final trading weeks of 2025. All of the major indices were hit hard ...

Bristol Myers’ stock rallied Wednesday as investors maintained high hopes for Cobenfy as an Alzheimer’s treatment, even ...

By Jonathan Stempel NEW YORK, Dec 1 (Reuters) - A U.S. judge on Monday rejected Bristol Myers Squibb's bid to dismiss a $6.7 ...

Global interim Phase 2 data in locally advanced/metastatic triple-negative breast cancer (”TNBC”) show encouraging antitumor activity for ...

BioNTech and Bristol Myers Squibb share positive data from Phase 2 trial of pumitamig plus chemotherapy for triple-negative ...

The futures are trading mixed as we get set to close out a wild and woolly week that saw a touch of just about everything.